11/01/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:30 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
8:01 AM | Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/30/2024
11:15 PM | Tonix Pharmaceuticals (Filer)
| Form EFFECT | |
09/27/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
09/23/2024
6:08 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:03 PM | Tonix Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/19/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
6:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
4:00 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
09/10/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
08/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
6:02 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
5:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:18 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/15/2024
5:03 AM | Tonix Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/12/2024
7:18 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:22 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/25/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
4:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
07/16/2024
8:12 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:48 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:33 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
4:01 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
5:45 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
3:52 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
Ticking time bomb. Detonation Nov 5 (Ad) Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election.
With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late.  Watch this video, it is being taken down Monday night |
06/26/2024
3:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
06/13/2024
4:24 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/10/2024
7:53 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
10:21 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
4:10 PM | Taylor Carolyn E. (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:56 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form ARS | |
04/15/2024
3:38 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
04/05/2024
3:47 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
03/29/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:03 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
8:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
8:48 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:01 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4/A | |
03/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:05 PM | SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:06 PM | MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:07 PM | SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:08 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
6:00 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:31 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
3:53 PM | Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
4:07 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:33 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
01/02/2024
3:15 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
12/26/2023
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
12/21/2023
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
12/21/2023
4:15 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
12/21/2023
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
9:31 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Ticking time bomb. Detonation Nov 5 (Ad) Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election.
With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night |
12/12/2023
6:00 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
6:10 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:23 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:27 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Free TNXP Stock Alerts